​

Correctional Psychiatric Services (CPS) is a recognized leader in the provision of Medication-Assisted Treatment (MAT) services in New England. As the only correctional healthcare vendor in Massachusetts with a full Opioid Treatment Program license (OTP), we have established ourselves as experts in the field of opioid treatment in corrections. At CPS, we are committed to staying at the forefront of best practices in this rapidly evolving area of behavioral and substance use treatment.

 

Our partnerships range from just offering one form of MAT to offering all three forms: methadone, buprenorphine, and naltrexone.

​

At CPS, we have a seasoned management team that can provide expert guidance to help your facility develop and implement Medication-Assisted Treatment (MAT) protocols. With our knowledge and expertise, we can assist you in navigating the complex landscape of substance use treatment in corrections and help you improve patient outcomes.

 

Our program is tailored to meet the specific requirements of correctional healthcare, including the challenges of providing care in a secure environment. We have a team of experts who work closely with facilities to develop and implement evidence-based MAT programs that are effective, safe, and compliant with regulatory standards.

 

With our program, correctional facilities can be assured that they are providing the best possible care to individuals struggling with opioid dependence. Let us work with you to develop effective and evidence-based MAT strategies tailored to your facility's unique needs.

 

 

Clinical Staff

Our clinical team is comprised of highly experienced medical, psychiatric, and behavioral health professionals, each with a deep understanding of correctional healthcare. They have extensive experience providing MAT/MOUD services to incarcerated individuals and are dedicated to delivering the highest quality care possible.

 

With our team’s expertise, we can offer comprehensive MAT/MOUD programs that are tailored to meet the unique needs of our patients. Our clinical staff is committed to helping individuals overcome substance use disorders and achieve long-term recovery, even in the challenging environment of correctional facilities.

 

With CPS, facilities can be confident that they are working with a trusted partner who is dedicated to providing the highest quality MAT/MOUD services.

​

​

WHAT ARE "MAT" & "MOUD"?

MAT stands for medication-assisted treatment, and it involves the use of Food and Drug Administration (FDA) approved such as:

• Acamprosate, disulfiram and naltrexone to treat alcohol use disorders.

• Methadone, buprenorphine, and naltrexone to treat opioid use disorders.

 

These medications are evidence-based treatment options and are not substitutes for other drugs.

​

MAT is Not Only Medication

MAT does not only mean providing medications, but it also involves providing counseling and behavioral care, and adopting a “whole person” approach to the treatment of substance use disorders.

 

MOUD

MOUD stands for Medications for Opioid Use Disorder. SAMHSA recommends using the term MOUD instead of MAT because MAT implies that medication plays a secondary role to other approaches such as counseling. In contrast, the term “MOUD” highlights an approach that sees medication as its own treatment form.  

 

 

What are the benefits of MAT?

According to SAMHSA, MAT has proved to be clinically effective and associated with important benefits including:

 

• Improving patient survival

• Promoting recovery and increasing retention in treatment

• Decreasing illicit opiate use and other criminal activity

• Reducing arrests, probation revocations and re-incarcerations

• Increasing patients’ ability to gain and maintain employment

• Improving birth outcomes for pregnant women with substance use disorders

• Lowering the risk of contracting HIV and hepatitis C

To read more about how MAT may benefit individuals involved with the Criminal Justice System, please click here.